Independent Portfolio Consultants’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Independent Portfolio Consultants's GILD Position: Q2 2017 in Review
Independent Portfolio Consultants increased its Gilead Sciences (GILD) stake by 101% in Q2 2017, buying an estimated $610K and bringing the position to 18,230 shares worth $1.29M. The position accounts for 0.54% of the portfolio, ranked #32.
Independent Portfolio Consultants first reported a position in GILD in Q2 2013 and has held it in 16 quarters since. The position peaked at $2.79M in Q3 2015. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.
- Independent Portfolio Consultants held 18,230 shares of Gilead Sciences worth $1.29M as of Q2 2017.
- Independent Portfolio Consultants bought 9,173 Gilead Sciences shares in Q2 2017, an estimated $610K.
- Gilead Sciences made up 0.54% of Independent Portfolio Consultants's portfolio in Q2 2017, its #32 holding.
- Independent Portfolio Consultants first reported a position in Gilead Sciences in Q2 2013 and has held it in 16 quarters since.
- Independent Portfolio Consultants's Gilead Sciences position peaked at $2.79M in Q3 2015.
- 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.
Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.